Although the DEA has given their approval to allow for electronic prescribing of controlled substances, the DEA technical requirements to do so involve several layers. Prior to electronic prescribing of controlled substances, pharmacies, providers and vendors will need to implement extensive security and technical measures. As a result, pharmacies are not expected to see their first electronically prescribed schedule II, III, IV and V drugs before at least year-end. SureScripts, the nation’s largest e-prescribing network, is working closely with pharmacies, health plans, vendors, etc. to analyze and act on the DEA’s requirements. For now, providers are to continue their current method of prescribing controlled substances.